|Avivagen Inc -- Canada Stock|| |
CAD 0.95 0.01 1.06%
Mr. Amin I. Khalifa is Independent Director of Avivagen Inc. He was Oct 2010 to present CFO Corporationrationrate Vice President, Iris International Inc., January 2008 to September 2010 Principal Khalifa Management Consulting, August 2006 to September 2007 Executive Vice President CFO Leap Wireless, August 2003 to August 2006 Executive Vice President CFO Apria Healthcare.
Director Since 2011
The company has return on total asset (ROA)
of (57.97) %
which means that it has lost $57.97 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE)
of (312.77) %
meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 1.22 M in total debt with debt to equity ratio (D/E) of 45.8 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Avivagen Inc has Current Ratio of 5.93 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.
Avivagen, Inc. develops and commercializes various products to replace antibiotics in livestock feeds to optimize the health and growth of the animals by supporting the animals own health defenses. The company was formerly known as Chemaphor, Inc. and changed its name to Avivagen, Inc. in May 2012. Avivagen is traded on TSX Venture Exchange in Canada.Avivagen Inc (VIV) is traded on TSX Venture Exchange in Canada. It is located in 100 Sussex Drive and employs 19 people.